NCT03778996View on ClinicalTrials.gov

SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

January 3, 2020

Primary Completion Date

December 19, 2027

Study Completion Date

March 31, 2028

Conditions
Sarcoma, EwingSarcoma
Interventions
DRUG

Combination metyrosine-derivative, low-dose methoxsalen, phenytoin and sirolimus (MPS)

Daily oral combination therapy for cancer

Trial Locations (1)

90403

Sarcoma Oncology Research Center, Santa Monica

All Listed Sponsors
collaborator

Tyme, Inc

INDUSTRY

lead

Sarcoma Oncology Research Center, LLC

OTHER

NCT03778996 - SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma | Biotech Hunter | Biotech Hunter